Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a global pharmaceutical company that develops, manufactures, and markets a wide range of drugs and vaccines. It was founded in 1891 by George Merck and is headquartered in Kenilworth, New Jersey. The company is known for its innovative research and development and has a strong commitment to corporate social responsibility.
Company Info
ISIN | US58933Y1055 |
---|---|
CUSIP | 58933Y105 |
Sector | Healthcare |
Industry | Drug Manufacturers—General |
Highlights
Market Cap | $318.60B |
---|---|
EPS | $0.14 |
PE Ratio | 898.43 |
PEG Ratio | 0.10 |
Revenue (TTM) | $60.12B |
Gross Profit (TTM) | $42.08B |
EBITDA (TTM) | $8.30B |
Year Range | $97.81 - $133.10 |
Target Price | $137.02 |
Short % | 0.77% |
Short Ratio | 1.77 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: MRK vs. PFE, MRK vs. BMY, MRK vs. VOO, MRK vs. NVO, MRK vs. SCHD, MRK vs. ABBV, MRK vs. AAPL, MRK vs. VHT, MRK vs. VTIP, MRK vs. O
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Merck & Co., Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Merck & Co., Inc. had a return of 20.67% year-to-date (YTD) and 18.40% in the last 12 months. Over the past 10 years, Merck & Co., Inc. had an annualized return of 12.65%, outperforming the S&P 500 benchmark which had an annualized return of 10.46%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 20.67% | 5.84% |
1 month | 4.14% | -2.98% |
6 months | 25.53% | 22.02% |
1 year | 18.40% | 24.47% |
5 years (annualized) | 15.83% | 11.44% |
10 years (annualized) | 12.65% | 10.46% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 10.79% | 5.27% | 4.43% | |||||||||
2023 | -4.89% | -0.24% | -0.21% | 7.15% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Merck & Co., Inc.(MRK)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Merck & Co., Inc. granted a 2.29% dividend yield in the last twelve months. The annual payout for that period amounted to $3.00 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | $3.00 | $2.96 | $2.80 | $2.61 | $2.36 | $2.15 | $1.90 | $1.80 | $1.76 | $1.73 | $1.69 | $1.65 |
Dividend yield | 2.29% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.42% | 3.11% | 3.45% |
Monthly Dividends
The table displays the monthly dividend distributions for Merck & Co., Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $0.00 | $0.00 | $0.77 | |||||||||
2023 | $0.00 | $0.00 | $0.73 | $0.00 | $0.00 | $0.73 | $0.00 | $0.00 | $0.73 | $0.00 | $0.00 | $0.77 |
2022 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.73 |
2021 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.69 |
2020 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.62 |
2019 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.58 |
2018 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.52 |
2017 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.46 |
2016 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.45 |
2015 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.44 |
2014 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.43 |
2013 | $0.41 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.42 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Merck & Co., Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Merck & Co., Inc. was 68.63%, occurring on Mar 9, 2009. Recovery took 1239 trading sessions.
The current Merck & Co., Inc. drawdown is 0.93%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-68.63% | Dec 29, 2000 | 2057 | Mar 9, 2009 | 1239 | Feb 7, 2014 | 3296 |
-49.96% | Mar 14, 1973 | 381 | Sep 13, 1974 | 1590 | Dec 30, 1980 | 1971 |
-47.25% | Jan 6, 1992 | 408 | Aug 13, 1993 | 494 | Jul 28, 1995 | 902 |
-36.5% | Mar 23, 1999 | 243 | Mar 7, 2000 | 160 | Oct 23, 2000 | 403 |
-35.03% | Jun 10, 1981 | 299 | Aug 13, 1982 | 236 | Jul 20, 1983 | 535 |
Volatility
Volatility Chart
The current Merck & Co., Inc. volatility is 6.37%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |